Alvotech

ALVO Nasdaq SEC CIK 1898416
Follow Alvotech Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · IFRS
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$1B−$500M$0$500M$1BFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$586.3M$27.9M
FY24$489.7M−$231.9M
FY23$91.4M−$551.7M
FY22$83M−$513.6M
FY21$36.8M−$101.5M
FY20$66.6M−$170M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−800%−600%−400%−200%0%200%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2559.8%13.3%4.8%
FY2462.2%14.2%−47.3%
FY23−75.9%−388.1%−603.4%
FY2222.8%−417.3%−618.6%
FY21100%−640.3%−276%
FY20-−206.5%−255.3%
FY19---
Free cash flowOperating cash flow minus capital expenditure
−$400M−$300M−$200M−$100M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$114.7M
FY24−$290.5M
FY23−$345.4M
FY22−$350.3M
FY21−$248.6M
FY20−$81.8M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Alvotech
  • Healthcare median
−800%−600%−400%−200%0%200%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearAlvotechHealthcare median
FY254.8%−30.6%
FY24−47.3%−47%
FY23−603.4%−58%
FY22−618.6%−80.4%
FY21−276%−71.9%
FY20−255.3%−62.2%
FY19-−46.3%